Why are pharmaceutical companies gradually abandoning vaccines?

During the past fifty years, the number of pharmaceutical companies making vaccines has decreased dramatically, and those that still make vaccines have reduced resources to make new ones. Pharmaceutical companies are gradually abandoning vaccines because the research, development, testing, and manufacture of vaccines are expensive and because the market to sell vaccines is much smaller than the market for other drug products. Congressional action could assure both a steady supply of existing vaccines and the promise of vaccines for the future.

[1]  R. Manning.  Changing Rules in Tort Law and the Market for Childhood Vaccines , 1994, The Journal of Law and Economics.

[2]  S. Malawista,et al.  A vaccine consisting of recombinant Borrelia burgdorferi outer-surface protein A to prevent Lyme disease. Recombinant Outer-Surface Protein A Lyme Disease Vaccine Study Consortium. , 1998, The New England journal of medicine.

[3]  Mads Melbye,et al.  Association Between Thimerosal-Containing Vaccine and Autism , 2003 .

[4]  Salk Je.  STUDIES in human subjects on active immunization against poliomyelitis. I. A preliminary report of experiments in progress. , 1953, Cyprus medical journal.

[5]  J. Wilson,et al.  Neurological complications of pertussis inoculation , 1974, Archives of disease in childhood.

[6]  B. Schwartz,et al.  Intussusception among infants given an oral rotavirus vaccine. , 2001, The New England journal of medicine.

[7]  N. Cox,et al.  Prevention and Control of Influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). , 2006, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[8]  Nick Andrews,et al.  Thimerosal Exposure in Infants and Developmental Disorders: A Retrospective Cohort Study in the United Kingdom Does Not Support a Causal Association , 2004, Pediatrics.

[9]  N. Nathanson.  Eradication of poliomyelitis in the United States. , 1982, Reviews of infectious diseases.

[10]  C. Schmid,et al.  Vaccination against Lyme disease with recombinant Borrelia burgdorferi outer-surface lipoprotein A with adjuvant. Lyme Disease Vaccine Study Group. , 1998, The New England journal of medicine.

[11]  Jon Cohen.  U.S. Vaccine Supply Falls Seriously Short , 2002, Science.

[12]  J. P. Davis,et al.  Strengthening the supply of routinely recommended vaccines in the United States: recommendations from the National Vaccine Advisory Committee. , 2003, JAMA.

[13]  Jane S. Smith,et al.  Patenting the Sun: Polio and the Salk Vaccine , 1990 .

[14]  D. Kasper,et al.  Immunization of Pregnant Women with a Polysaccharide Vaccine of Group B Streptococcus , 1988 .